Be Biopharma, Inc. ("Be Bio"), a clinical-stage company pioneering the discovery and development of engineered B Cell Medicines (BCMs), today presented results from new preclinical research ...

Welcome to the Q3 2025 Brady Corporation earnings conference call. At this time, all participants are in listen-only mode. Please be advised that today's conference is being recorded. After the ...